Menu
Proteimax was founded in 2001 in Sao Paulo, Brazil by leading scientists, Prof. Emer S. Ferro and Andrea Sterman Heimann. Their initial goal was to develop a method of screening, identifying, and commercializing antibodies and naturally occurring peptides, which are small proteins, for the pharmaceutical industry and basic research.
The unique screening method that was developed by the Proteimax team allowed them to bring to market several antibodies with the ability to identify changes in receptors that are affected by specific stress conditions.
In 2006, the science team decided to point their screening method to the mammalian endocannabinoid system in order to search for new peptides that can activate that system’s receptors. At the time, it was commonly thought that only cannabinoids can activate these receptors.
In 2007, after screening thousands of candidates, a new family of 54 peptides was discovered and registered. Some of these peptides modulate cannabinoid receptors. Based on current knowledge, they appear to show potential to solve some of the most pressing challenges of humanity, from obesity and type 2 diabetes to certain neurological disorders to the certain cancers.
Surgeon, scientist, and entrepreneur. Cloned the rabbit androgen receptor. Co-authored first study showing cancer prevention w nutritional supplement. Introduced laparoscopic radical prostatectomy. Writes about food and fitness.
Currently holds full professor position at the University of São Paulo and is in charge on the Laboratory of Pharmacology of Intracellular Peptides that study the recycling of biological activity and the discovery of new peptide drugs.
Itamar Raz, MD is board certified, full professor in
internal medicine, and was the Head of the Diabetes Unit at Hadassah Hebrew University Hospital between 2000-2015. He is currently Medical Director at the Diabetes Medical Center in Tel Aviv and the head of the Israeli council of diabetes, Prof. Raz has been involved in many various academic activities.
Frank Greenway, MD is Medical Director of the Pennington Biomedical Research Center at Louisiana State University. His interest includes supplements and medical foods for the metabolic and functional effects in the obese.
Dr. Goldman is a Hans Fischer Senior Fellow and Professor at the University of São Paulo. He specializes in fungal genetics and antifungal resistance, with a focus on Aspergillus fumigatus. Dr. Goldman has authored 300+ publications, is a member of various societies, and received the 2021 ASM Moselio Schaechter Award. He received degrees from universities in Brazil, Belgium, and the USA.
Dr. Rollins directs the Obesity Center at the College of Veterinary Medicine at the University of Tennessee. She’s authored numerous publications on animal nutrition with a primary focus on companion animal obesity. Dr. Rollins holds a Doctor of Veterinary Medicine and PhD in Comparative and Experimental Medicine.
Surgeon, scientist, and entrepreneur. Cloned the rabbit androgen receptor. Co-authored first study showing cancer prevention w nutritional supplement. Introduced laparoscopic radical prostatectomy. Writes about food and fitness.
Currently holds full professor position at the University of São Paulo and is in charge on the Laboratory of Pharmacology of Intracellular Peptides that study the recycling of biological activity and the discovery of new peptide drugs.
Itamar Raz, MD is board certified, full professor in
internal medicine, and was the Head of the Diabetes Unit at Hadassah Hebrew University Hospital between 2000-2015. He is currently Medical Director at the Diabetes Medical Center in Tel Aviv and the head of the Israeli council of diabetes, Prof. Raz has been involved in many various academic activities.
Frank Greenway, MD is Medical Director of the Pennington Biomedical Research Center at Louisiana State University. His interest includes supplements and medical foods for the metabolic and functional effects in the obese.
Dr. Goldman is a Hans Fischer Senior Fellow and Professor at the University of São Paulo. He specializes in fungal genetics and antifungal resistance, with a focus on Aspergillus fumigatus. Dr. Goldman has authored 300+ publications, is a member of various societies, and received the 2021 ASM Moselio Schaechter Award. He received degrees from universities in Brazil, Belgium, and the USA.
Dr. Rollins directs the Obesity Center at the College of Veterinary Medicine at the University of Tennessee. She’s authored numerous publications on animal nutrition with a primary focus on companion animal obesity. Dr. Rollins holds a Doctor of Veterinary Medicine and PhD in Comparative and Experimental Medicine.
We will do our best to get back to you ASAP
Site by: DavidCasirer.com